Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers

Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers

Bibliographic Details
Main Authors: Bryant, Christopher, Rawlinson, Rebecca, Massey, Andrew J
Format: Online
Language:English
Published: BioMed Central 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137066/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137066/

Similar Items